Ambry Debuts New Cytogenomic Cancer Dx Chips; OGT, Signature Ready Theirs
September 13, 2011
Ambry Debuts New Cytogenomic Cancer Dx Chips; OGT, Signature Ready Theirs
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- In 2010, Array Makers Saw CGH Become the Standard in Cytogenetics, Prepared for Next Wave of GWAS
January 4, 2011 / BioArray News - In Bid to Court Cancer Cyto Community, OGT Prepares CCMC-Designed Chip for Launch
February 26, 2013 / BioArray News - OGT Inks Deal with CCMC to Build Cancer Microarray
February 26, 2013 / GenomeWeb Daily News - Signature Genomics to Adopt Agilent Platform in Light of Roche's Planned Departure from Array Market
July 31, 2012 / BioArray News - With SNP Content on the Rise for Cytogenetics, Do CGH Arrays Have a Future?
April 17, 2012 / BioArray News